Importantly, no articles have reported HGD and GSTZ1 as potential biomarkers of KIRC, so our study is the first to identify HGD and GSTZ1 as tumor biomarkers, which fills the gap of tyrosine metabolism in the field of tumor markers. This evidence concerns the gene GSTZ1 and neoplasm.